Boston follows Medtronic's footsteps and buys into TAVI space
This article was originally published in Clinica
Boston Scientific is to buy outright a company in its investment portfolio, Sadra Medical. The firm specialises in percutaneous transcatheter aortic valve implantation (TAVI) technology and the acquisition follows in the footsteps of heart rival Medtronic, which last year bought two venture-backed TAVI companies – CoreValve and Ventor Technologies – for just under $1bn (www.clinica.co.uk, 2 March 2009).
You may also be interested in...
Founded and led by serial entrepreneur Amr Salahieh, Apama Medical is developing a system that aims to combine the advantages of two approaches for treating atrial fibrillation: point-by-point radiofrequency-based ablation and cryoballoon ablation.
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.